SPL, SPM… two acronyms that carry a lot of weight in the world of regulatory compliance. Whether you're just getting started or have experience navigating these structures, this webinar is packed with insights, clarifications, and expert answers to both common and uncommon questions.

As FHIR gains momentum in pharma and life sciences organizations, we put together a list of frequently asked questions regarding this spec.

IMPORTANT UPDATE: On February 14, 2022, the FDA designated the February 14 deadline as a recommendation and not a requirement. This...